-
3 weeks ago | 
dotmed.com | Gus Iversen
Capitol Imaging Services has expanded its reach into Georgia through the acquisition of Outpatient Imaging, LLC, a network of nine diagnostic centers located in the greater Atlanta area and Statesboro. The acquisition was made by Capitol Imaging’s parent company, Clearview Capital Fund IV, L.P., a Stamford, Connecticut-based private equity fund.
-
3 weeks ago | 
dotmed.com | Gus Iversen
ChristianaCare will take over operations at five Crozer Health outpatient centers in Pennsylvania after submitting the winning $50.3 million bid in a court-supervised auction process tied to Crozer’s ongoing bankruptcy. The Wilmington, Delaware-based health system plans to assume control of facilities located in Glen Mills, Havertown, Broomall, and Media, all in Delaware County. The transaction remains subject to court approval and is expected to close soon.
-
3 weeks ago | 
dotmed.com | Gus Iversen
GE HealthCare has partnered with Forsta, a subsidiary of Kalbe, to open Indonesia’s first facility dedicated to the domestic production of CT scanners. The site, located at PT Forsta Kalmedic Global in Bogor, marks a shift toward localized manufacturing of advanced diagnostic technology. The partnership aims to shorten delivery times, reduce reliance on imported imaging systems, and expand access to diagnostics across Indonesia’s archipelago.
-
3 weeks ago | 
dotmed.com | Gus Iversen
The U.S. Food and Drug Administration has granted De Novo authorization to CLAIRITY BREAST, an AI platform developed by Clairity, Inc., for predicting five-year breast cancer risk using only a screening mammogram. The Boston-based startup says the tool is designed to integrate with existing clinical systems, allowing providers to identify women at elevated risk without relying on traditional factors such as family history or genetic background.
-
3 weeks ago | 
dotmed.com | Gus Iversen
As nuclear medicine enters a transformative era defined by rapid innovation, expanding clinical impact, and unprecedented growth, few are better positioned to guide the field than SNMMI's president-elect, Dr. Jean-Luc Urbain.
-
3 weeks ago | 
dotmed.com | Gus Iversen
The Georgia Attorney General’s Office has approved the integration of Houston Healthcare into the Emory Healthcare system, clearing the way for the Warner Robins-based provider to officially join the Atlanta-based academic health network. The move follows a regulatory process that began in August 2024, when the two systems signed a letter of intent to explore a partnership. A definitive agreement was finalized in February 2025, outlining terms of the affiliation.
-
3 weeks ago | 
dotmed.com | Gus Iversen
Medical technology firm Hologic has reportedly declined a $16 billion buyout proposal from private equity groups TPG and Blackstone, according to individuals familiar with the matter. The offer, which was nonbinding, would have valued the Marlborough, Massachusetts-based company between $16.3 billion and $16.7 billion including debt, translating to a per-share range of $70 to $72. Hologic shares closed at $54.28 the Friday before news of the offer broke.
-
3 weeks ago | 
dotmed.com | Gus Iversen
Researchers at the University of Osaka have identified key conditions under which ultra-high dose rate (uHDR) carbon ion radiation can reduce damage to healthy cells, a finding that may someday expand the clinical use of carbon ion therapy with fewer side effects. The study, published in Anticancer Research, marks the first documented observation of the so-called FLASH effect with carbon ion beams under normoxic (normal oxygen) conditions.
-
3 weeks ago | 
dotmed.com | Gus Iversen
Restore Robotics has reported the first human procedures using its remanufactured da Vinci Xi robotic instruments, following FDA clearance for the devices. The company, based in Panama City Beach, Florida, holds the only FDA clearance to remanufacture da Vinci Xi instruments and currently offers them through Encore Medical Device Repair, its commercial partner.
-
3 weeks ago | 
dotmed.com | Gus Iversen
A team at the Weizmann Institute of Science has developed an MR system capable of resolving structures down to one nanometer—about one-billionth of a meter. The development marks a significant step toward visualizing individual atoms within a molecule and could offer new capabilities in molecular imaging for research and industry.
